Javascript must be enabled to continue!
Diagnosis and treatment of portal vein thrombosis following splenectomy
View through CrossRef
Abstract
Background
Portal vein thrombosis is a rare but potentially fatal complication of splenectomy. The aim of this study was to assess the incidence, risk factors, treatment and outcome of portal vein thrombosis after splenectomy in a large series of patients.
Methods
All patients who had undergone a splenectomy in the University Hospital, Rotterdam, between 1984 and 1997 were reviewed retrospectively. Splenectomy that was followed by symptomatic portal vein thrombosis was selected for analysis. Risk factors for portal vein thrombosis were sought.
Results
Of 563 splenectomies, nine (2 per cent) were complicated by symptomatic portal vein thrombosis. All these patients had either fever or abdominal pain. Two of 16 patients with a myeloproliferative disorder developed portal vein thrombosis after splenectomy (P = 0·03), and four of 49 patients with haemolytic anaemia (P = 0·005). Treatment within 10 days after splenectomy was successful in all patients, while delayed treatment was ineffective.
Conclusion
Portal vein thrombosis should be suspected in a patient with fever or abdominal pain after splenectomy. Patients with a myeloproliferative disorder or haemolytic anaemia are at higher risk; they might benefit from early detection and could have routine Doppler ultrasonography after splenectomy.
Oxford University Press (OUP)
Title: Diagnosis and treatment of portal vein thrombosis following splenectomy
Description:
Abstract
Background
Portal vein thrombosis is a rare but potentially fatal complication of splenectomy.
The aim of this study was to assess the incidence, risk factors, treatment and outcome of portal vein thrombosis after splenectomy in a large series of patients.
Methods
All patients who had undergone a splenectomy in the University Hospital, Rotterdam, between 1984 and 1997 were reviewed retrospectively.
Splenectomy that was followed by symptomatic portal vein thrombosis was selected for analysis.
Risk factors for portal vein thrombosis were sought.
Results
Of 563 splenectomies, nine (2 per cent) were complicated by symptomatic portal vein thrombosis.
All these patients had either fever or abdominal pain.
Two of 16 patients with a myeloproliferative disorder developed portal vein thrombosis after splenectomy (P = 0·03), and four of 49 patients with haemolytic anaemia (P = 0·005).
Treatment within 10 days after splenectomy was successful in all patients, while delayed treatment was ineffective.
Conclusion
Portal vein thrombosis should be suspected in a patient with fever or abdominal pain after splenectomy.
Patients with a myeloproliferative disorder or haemolytic anaemia are at higher risk; they might benefit from early detection and could have routine Doppler ultrasonography after splenectomy.
Related Results
The Prevalence of JAK2 Mutation in High-Altitude Patients with Unprovoked Thrombosis and Thrombosis at Unusual Sites
The Prevalence of JAK2 Mutation in High-Altitude Patients with Unprovoked Thrombosis and Thrombosis at Unusual Sites
Introduction
Thrombosis, both arterial and venous, is a major source of morbidity and mortality in patients with myeloproliferative neoplasms (MPNs). Thrombosis can ...
Venous Thromboembolism in Denmark: Seasonality in Occurrence and Mortality
Venous Thromboembolism in Denmark: Seasonality in Occurrence and Mortality
Background Many cardiovascular conditions exhibit seasonality in occurrence and mortality, but little is known about the seasonality of venous thromboembolism.
Methods ...
Non-Cirrhotic Splanchnic Vein Thrombosis: When Is Anticoagulation Enough?
Non-Cirrhotic Splanchnic Vein Thrombosis: When Is Anticoagulation Enough?
Abstract
Abstract 3390
Background:
In the absence of primary liver disease, thrombosis of the splanchnic vessels ...
Splenectomy Does Not Improve Survival in Chronic Active Epstein-Barr Virus Disease Patients
Splenectomy Does Not Improve Survival in Chronic Active Epstein-Barr Virus Disease Patients
Abstract
Purpose
We aimed to evaluate the clinical value of splenectomy as a treatment for Chronic active Epstein-Barr virus disease (CAEBVD).
Methods
We retrospectively r...
Portal Vein Thrombosis in a Patient with Type 1 Diabetes Presenting as Acute Pyelonephritis
Portal Vein Thrombosis in a Patient with Type 1 Diabetes Presenting as Acute Pyelonephritis
Background: Few cases have been reported with respect to portal vein thrombosis in non-cirrhotic patients. Asymptomatic or non-specific symptoms of portal vein thrombosis may lead ...
Frequency of Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma
Frequency of Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma
The hepatocellular carcinoma (HCC) is a frequent complication of liver. Portal vein thrombosis is common in HCC patients and associated with poor prognosis. But evidence lacks for ...
Understanding Treatment Preferences In Patients with Primary Immune Thrombocytopenia Contemplating Splenectomy: A Qualitative Study
Understanding Treatment Preferences In Patients with Primary Immune Thrombocytopenia Contemplating Splenectomy: A Qualitative Study
Abstract
Abstract 392
Introduction
Primary immune thrombocytopenia (ITP) is a common autoimmune bleeding disorder...
Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection
Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection
Abstract
Background
Recent reports have shown that patients with vascular tumour invasion who undergo concurrent vascular resect...

